Episode 150: Myeloma Series, Pt. 10 - Role of CAR T for relapsed/refractory multiple myeloma (2026)
About this episode
This episode explores the role of CAR T therapy in treating relapsed/refractory multiple myeloma.
In this week’s episode, we take a practical dive into the relapsed/refractory myeloma space, with a focus on the role of CAR T therapy for relapsed/refractory. In our next episode, we will continue on with a discussion on bispecific agents! This is a conversation that is so important in the current treatment landscape and one that you don’t want to miss. Content: - What are treatment options for patients with relapsed/refractory multiple myeloma (R/R MM)? - What is CAR T therapy? And what role does it play in R/R MM? - What are the available options for CAR T for R/R MM? - What are the toxicity profiles of available agents? - How to choose between the options? ** This episode is sponsored by The Lymphoma, Leukemia and Myeloma Congress! To learn more and register for the meeting, visit llmcongress.com/podcast ! Be sure to use our special TFOC code TFOC40 to save 40% off registration. ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Youtube
Topics covered
- relapsed/refractory multiple myeloma
- CAR T therapy
- treatment options
- toxicity profiles
- bispecific agents
Keywords
- CAR T therapy
- relapsed/refractory myeloma
- treatment options
- toxicity profiles
- bispecific agents
Sponsors
The Lymphoma, Leukemia and Myeloma Congress
Mentioned in this episode
Organizations: Rouleaux University Medical Center
Books & works: Episode 150: Myeloma Series, Pt. 10 - Role of CAR T for relapsed/refractory multiple myeloma
More episodes of The Fellow on Call: The Heme/Onc Podcast
- Episode 157: Immune Thrombocytopenic Purpura Series, Pt 3- Challenging Scenarios in ITP
- Episode 156: Immune Thrombocytopenic Purpura Series, Pt 2- Relapsed/Refractory
- Episode 155: Immune Thrombocytopenic Purpura Series, Pt 1- First Line Management
- Episode 154: Ask The Program Directors-The Do’s and Don'ts of Applying to Hematology Fellowship (Career Development Series)
- Episode 153: Myeloma Capstone, Pt 2 - MRD-Guided Therapy, Maintenance, and Relapsed/Refractory Sequencing
- Episode 152: Myeloma Capstone, Pt 1 - Smoldering Myeloma & Frontline Treatment in the Elderly
Explore listener stats, chart rankings, contacts and more on the The Fellow on Call: The Heme/Onc Podcast podcast page.